Morgan Stanley
JHMH

Morgan Stanley’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Morgan Stanley’s Portfolio JHMH Stock Details JHMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 8143
2022
Q3 		$0 Hold
1
– – ﹤0.01% 8108
2022
Q2 		$0 Sell
1
-31
-97% -$1.46K ﹤0.01% 8214
2022
Q1 		$2K Hold
32
– – ﹤0.01% 7808
2021
Q4 		$2K Hold
32
– – ﹤0.01% 7835
2021
Q3 		$2K Hold
32
– – ﹤0.01% 7723
2021
Q2 		$2K Sell
32
-868
-96% -$40.4K ﹤0.01% 7566
2021
Q1 		$40K Buy
+900
New +$39.8K ﹤0.01% 6456
2020
Q1 		– Sell
-762
Closed -$28K – 6802
2019
Q4 		$28K Hold
762
– – ﹤0.01% 6022
2019
Q3 		$25K Hold
762
– – ﹤0.01% 5949
2019
Q2 		$26K Hold
762
– – ﹤0.01% 5845
2019
Q1 		$26K Hold
762
– – ﹤0.01% 5931
2018
Q4 		$24K Hold
762
– – ﹤0.01% 5983
2018
Q3 		$28K Hold
762
– – ﹤0.01% 6048
2018
Q2 		$24K Buy
+762
New +$24.1K ﹤0.01% 6111

Morgan Stanley's JHMH Position: Q4 2022 in Review

Morgan Stanley sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 1 share.

Morgan Stanley first reported a position in JHMH in Q2 2018 and held it in 14 quarters. The position peaked at $40K in Q1 2021. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.

  • Morgan Stanley reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 1 John Hancock Multifactor Healthcare ETF share in Q4 2022.
  • Morgan Stanley first reported a position in John Hancock Multifactor Healthcare ETF in Q2 2018 and held it in 14 quarters.
  • Morgan Stanley's John Hancock Multifactor Healthcare ETF position peaked at $40K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.